Calithera Biosciences
CALA
$0.02000
Share price
0.00%
Change (1 day)
-33.33%
Change (1 year)
Categories
Calithera Biosciences (CALA) - Cash on Hand
Cash on Hand as of December 2022 : $25.45 M
According to Calithera Biosciences
's latest financial reports the company has $25.45 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Calithera Biosciences - Cash on Hand chart (from 2013 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $25.45 M | -57.25% |
| 2021-12-31 | $59.53 M | -48.3% |
| 2020-12-31 | $0.11 B | -26.82% |
| 2019-12-31 | $0.15 B | 15.58% |
| 2018-12-31 | $0.13 B | -16.87% |
| 2017-12-31 | $0.16 B | 216.32% |
| 2016-12-31 | $51.78 M | -25.95% |
| 2015-12-31 | $69.92 M | -31.42% |
| 2014-12-31 | $0.10 B | 201.51% |
| 2013-12-31 | $33.82 M | 1433.79% |
| 2012-12-31 | $2.2 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $7.26 B | 28,441.12% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $34.01 M | 33.65% | 🇺🇸 USA |